DEA Rescheduling Bet May Backfire as THCA Hemp Loophole Widens

The Rescheduling Timeline vs. Market Reality

The DEA's proposed rule to reschedule marijuana to Schedule III has been pending since May 2024, with no final action date set. The agency received over 43,000 public comments during the initial comment period and faces additional procedural steps including an administrative law judge hearing. Meanwhile, THCA-dominant hemp products—legal under the 2018 Farm Bill's 0.3% delta-9 THC threshold—have flooded retail channels in 38 states.

The math is simple. THCA converts to delta-9 THC upon heating, but federal testing protocols measure only pre-decarboxylation delta-9 levels. A flower testing at 25% THCA and 0.2% delta-9 is federally compliant hemp. Smoke that same flower? You get the same psychoactive load as traditional marijuana.

Why Operators Are Hedging Their Bets

At least 12 MSOs have quietly launched THCA-branded product lines in the past six months, according to wholesale transaction data. The strategic calculus: if rescheduling stalls or fails, THCA hemp offers an immediate nationwide distribution channel without state licensing bottlenecks or 280E tax penalties.

The rescheduling process was supposed to be the industry's regulatory off-ramp. Instead, it's become a slow-motion bet against a faster-moving loophole.

Key operator advantages of the THCA pathway:

• No state cannabis license required in most jurisdictions
• Interstate commerce permitted under federal law
• Standard business deductions available (no 280E penalty)
• Lower compliance and testing costs in hemp-only states

The downside: regulatory uncertainty. The DEA and FDA haven't issued formal guidance on THCA-dominant products, and state-level enforcement varies wildly. Ohio and Minnesota have moved to close the loophole through emergency rules. Oregon and Michigan haven't.

What Happens If Rescheduling Lands

Even if the DEA finalizes Schedule III placement in 2027, the THCA pathway may remain the more attractive option for multi-state operators. Schedule III status would eliminate federal criminal penalties but wouldn't resolve state-by-state licensing fragmentation or trigger interstate commerce rights. THCA hemp already operates in that space.

Enforcement is the wildcard. The DEA could issue an interpretive rule clarifying that THCA is a "total THC" analog subject to scheduling, but that would require notice-and-comment rulemaking and likely face court challenges under the Farm Bill's explicit carve-out for hemp. Right now, the loophole is open.

For full background on this story, see the CannIntel topic hub on DEA rescheduling.

The next signal: watch for state-level emergency rules targeting THCA in the 14 states with active legislative sessions this fall. Federal guidance remains unlikely before Q2 2027.